Skip to main content
OpenTrials
Completed

NCT Number: NCT04067583

A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information related to physician characteristics and experience with Aflibercept, as well as assess physicians' knowledge and understanding of storage and preparation, proper injection technique, and the risks associated with Aflibercept injection into the eye (intravitreal injection). Analysis will be done using descriptive statistics.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ophthalmology, Macular Degeneration Eye Diseases Macular Degeneration Retinal Degeneration Retinal Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Many locations

Multiple Locations, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Has signed informed consent
  • Is a licensed and practicing ophthalmologist
  • Has prescribed and/or administered aflibercept to at least one patient in the past 6 months

Exclusion criteria

  • None

Treatment and study plan

Physician questionnaire

Other

This is a one-time cross-sectional survey of physicians, conducted electronically; there are no in person visits

Primary outcomes

  1. Percentage of physicians responding correctly to each individual knowledge question

    Time frame: Up to 1 year

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Aug 26, 2019
Registry last updated
Apr 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.